-
@ Yahoo! Finance - by layer3.news
2025-05-08 04:44:51
nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aesst3mr8r
✍️ Veracyte's Relative Strength (RS) Rating was upgraded from 70 to 76, but the stock is still trading below its 50- and 200-day moving averages.
👉 Veracyte's RS Rating was upgraded from 70 to 76
👉 The stock is trading below its 50- and 200-day moving averages
👉 71% EPS growth and 21% revenue increase in the latest quarterly report
👉 Next quarterly results expected on or around May 7
👉 Veracyte holds the No. 10 rank among its peers in the Medical-Services industry group
#business
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq0w7j4j5egkv3ln09ufsc5rsz8v5vw7uu8txm8427hf2ecfpzpxqqmpfs6g